schliessen

Filtern

 

Bibliotheken

Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis

To evaluate the effectiveness of colorectal cancer (CRC) screening in asymptomatic adults. A search was conducted of the Medline, Embase, and the Cochrane Library databases. A targeted search of PubMed was conducted for on-topic randomized controlled trials (RCTs). Meta-analysis across 4 RCTs for gu... Full description

Journal Title: Clinical Colorectal Cancer December 2016, Vol.15(4), pp.298-313
Main Author: Fitzpatrick-Lewis, Donna
Other Authors: Ali, Muhammad Usman , Warren, Rachel , Kenny, Meghan , Sherifali, Diana , Raina, Parminder
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 1533-0028 ; E-ISSN: 1938-0674 ; DOI: 10.1016/j.clcc.2016.03.003
Link: http://dx.doi.org/10.1016/j.clcc.2016.03.003
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: elsevier_sdoi_10_1016_j_clcc_2016_03_003
title: Screening for Colorectal Cancer: A Systematic Review and Meta-Analysis
format: Article
creator:
  • Fitzpatrick-Lewis, Donna
  • Ali, Muhammad Usman
  • Warren, Rachel
  • Kenny, Meghan
  • Sherifali, Diana
  • Raina, Parminder
subjects:
  • Cancer
  • Colorectal
  • Screening
  • Systematic Review
  • Cancer
  • Colorectal
  • Screening
  • Systematic Review
  • Medicine
ispartof: Clinical Colorectal Cancer, December 2016, Vol.15(4), pp.298-313
description: To evaluate the effectiveness of colorectal cancer (CRC) screening in asymptomatic adults. A search was conducted of the Medline, Embase, and the Cochrane Library databases. A targeted search of PubMed was conducted for on-topic randomized controlled trials (RCTs). Meta-analysis across 4 RCTs for guaiac fecal occult blood testing (gFOBT) and flexible sigmoidoscopy (FS) screening showed a reduction of 18% (risk ratio [RR], 0.82; 95% CI [CI], 0.73-0.92) and 26% (RR, 0.74; 95% CI, 0.67-0.83) in CRC mortality for the screening group compared to controls, respectively. The number needed to screen (NNS) were 377 (95% CI, 249-887) and 864 (95% CI, 672-1266) for gFOBT and FS screening, respectively. A reduction of 8% and 27% in incidence of late-stage CRC was also observed for gFOBT and FS screening, respectively, but both had no significant effect on all-cause mortality. A single RCT found that screening with immunochemical fecal occult blood test (iFOBT) had no significant impact on...
language: eng
source:
identifier: ISSN: 1533-0028 ; E-ISSN: 1938-0674 ; DOI: 10.1016/j.clcc.2016.03.003
fulltext: fulltext
issn:
  • 1533-0028
  • 15330028
  • 1938-0674
  • 19380674
url: Link


@attributes
ID1348161305
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordiddoi_10_1016_j_clcc_2016_03_003
sourceidelsevier_s
recordidTN_elsevier_sdoi_10_1016_j_clcc_2016_03_003
sourcesystemPC
dbid
0--K
1--M
2.FO
3.~1
41P~
51~.
6457
74G.
87-5
98P~
10AAEDT
11AAKOC
12AAOAW
13AAQFI
14ABBQC
15ABMZM
16ABYKQ
17ACDAQ
18ACRLP
19ADALY
20AEKER
21AEVXI
22AFKWA
23AFTJW
24AFXIZ
25AGHFR
26AGUBO
27AGYEJ
28AIKHN
29AITUG
30AJBFU
31AJOXV
32AJRQY
33AJUYK
34AMFUW
35ANZVX
36BLXMC
37BNPGV
38FDB
39FGOYB
40FIRID
41FNPLU
42GBLVA
43KOM
44LCYCR
45OAUVE
46OC~
47OO-
48P-8
49P-9
50PC.
51Q38
52R2-
53SDF
54SEL
55SES
56SSH
57SSZ
58T5K
59Z5R
60~G-
pqid1826673036
galeid518125875
display
typearticle
titleScreening for Colorectal Cancer: A Systematic Review and Meta-Analysis
creatorFitzpatrick-Lewis, Donna ; Ali, Muhammad Usman ; Warren, Rachel ; Kenny, Meghan ; Sherifali, Diana ; Raina, Parminder
ispartofClinical Colorectal Cancer, December 2016, Vol.15(4), pp.298-313
identifier
subjectCancer ; Colorectal ; Screening ; Systematic Review ; Cancer ; Colorectal ; Screening ; Systematic Review ; Medicine
descriptionTo evaluate the effectiveness of colorectal cancer (CRC) screening in asymptomatic adults. A search was conducted of the Medline, Embase, and the Cochrane Library databases. A targeted search of PubMed was conducted for on-topic randomized controlled trials (RCTs). Meta-analysis across 4 RCTs for guaiac fecal occult blood testing (gFOBT) and flexible sigmoidoscopy (FS) screening showed a reduction of 18% (risk ratio [RR], 0.82; 95% CI [CI], 0.73-0.92) and 26% (RR, 0.74; 95% CI, 0.67-0.83) in CRC mortality for the screening group compared to controls, respectively. The number needed to screen (NNS) were 377 (95% CI, 249-887) and 864 (95% CI, 672-1266) for gFOBT and FS screening, respectively. A reduction of 8% and 27% in incidence of late-stage CRC was also observed for gFOBT and FS screening, respectively, but both had no significant effect on all-cause mortality. A single RCT found that screening with immunochemical fecal occult blood test (iFOBT) had no significant impact on...
languageeng
source
version8
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://dx.doi.org/10.1016/j.clcc.2016.03.003$$EView_record_in_ScienceDirect_(Access_to_full_text_may_be_restricted)
search
creatorcontrib
0Fitzpatrick-Lewis, Donna
1Ali, Muhammad Usman
2Warren, Rachel
3Kenny, Meghan
4Sherifali, Diana
5Raina, Parminder
titleScreening for Colorectal Cancer: A Systematic Review and Meta-Analysis
description

To evaluate the effectiveness of colorectal cancer (CRC) screening in asymptomatic adults. A search was conducted of the Medline, Embase, and the Cochrane Library databases. A targeted search of PubMed was conducted for on-topic randomized controlled trials (RCTs). Meta-analysis across 4 RCTs for guaiac fecal occult blood testing (gFOBT) and flexible sigmoidoscopy (FS) screening showed a reduction of 18% (risk ratio [RR], 0.82; 95% CI [CI], 0.73-0.92) and 26% (RR, 0.74; 95% CI, 0.67-0.83) in CRC mortality for the screening group compared to controls, respectively. The number needed to screen (NNS) were 377 (95% CI, 249-887) and 864 (95% CI, 672-1266) for gFOBT and FS screening, respectively. A reduction of 8% and 27% in incidence of late-stage CRC was also observed for gFOBT and FS screening, respectively, but both had no significant effect on all-cause mortality. A single RCT found that screening with immunochemical fecal occult blood test (iFOBT) had no significant impact on...

subject
0Cancer
1Colorectal
2Screening
3Systematic Review
4Medicine
general
0English
1Elsevier Inc
210.1016/j.clcc.2016.03.003
3ScienceDirect (Elsevier)
4ScienceDirect Journals (Elsevier)
sourceidelsevier_s
recordidelsevier_sdoi_10_1016_j_clcc_2016_03_003
issn
01533-0028
115330028
21938-0674
319380674
rsrctypearticle
creationdate2016
addtitleClinical Colorectal Cancer
searchscope
0elsevier_full
1elsevier2
scope
0elsevier_full
1elsevier2
lsr44$$EView_record_in_ScienceDirect_(Access_to_full_text_may_be_restricted)
tmp01ScienceDirect Journals (Elsevier)
tmp02
0--K
1--M
2.FO
3.~1
41P~
51~.
6457
74G.
87-5
98P~
10AAEDT
11AAKOC
12AAOAW
13AAQFI
14ABBQC
15ABMZM
16ABYKQ
17ACDAQ
18ACRLP
19ADALY
20AEKER
21AEVXI
22AFKWA
23AFTJW
24AFXIZ
25AGHFR
26AGUBO
27AGYEJ
28AIKHN
29AITUG
30AJBFU
31AJOXV
32AJRQY
33AJUYK
34AMFUW
35ANZVX
36BLXMC
37BNPGV
38FDB
39FGOYB
40FIRID
41FNPLU
42GBLVA
43KOM
44LCYCR
45OAUVE
46OC~
47OO-
48P-8
49P-9
50PC.
51Q38
52R2-
53SDF
54SEL
55SES
56SSH
57SSZ
58T5K
59Z5R
60~G-
orcidid0000-0002-8516-3057
startdate20161201
enddate20161231
lsr40Clinical Colorectal Cancer, December 2016, Vol.15 (4), pp.298-313
doi10.1016/j.clcc.2016.03.003
citationpf 298 pt 313 vol 15 issue 4
lsr30VSR-Enriched:[galeid, pqid]
sort
titleScreening for Colorectal Cancer: A Systematic Review and Meta-Analysis
authorFitzpatrick-Lewis, Donna ; Ali, Muhammad Usman ; Warren, Rachel ; Kenny, Meghan ; Sherifali, Diana ; Raina, Parminder
creationdate20161200
lso0120161200
facets
frbrgroupid3064436209586715322
frbrtype5
newrecords20190904
languageeng
topic
0Cancer
1Colorectal
2Screening
3Systematic Review
4Medicine
collectionScienceDirect (Elsevier)
prefilterarticles
rsrctypearticles
creatorcontrib
0Fitzpatrick-Lewis, Donna
1Ali, Muhammad Usman
2Warren, Rachel
3Kenny, Meghan
4Sherifali, Diana
5Raina, Parminder
jtitleClinical Colorectal Cancer
creationdate2016
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
orcidid0000-0002-8516-3057
aulast
0Fitzpatrick-Lewis
1Ali
2Warren
3Kenny
4Sherifali
5Raina
aufirst
0Donna
1Muhammad Usman
2Rachel
3Meghan
4Diana
5Parminder
auinitD
auinit1D
au
0Fitzpatrick-Lewis, Donna
1Ali, Muhammad Usman
2Warren, Rachel
3Kenny, Meghan
4Sherifali, Diana
5Raina, Parminder
atitleScreening for Colorectal Cancer: A Systematic Review and Meta-Analysis
jtitleClinical Colorectal Cancer
risdate201612
volume15
issue4
spage298
epage313
pages298-313
issn1533-0028
eissn1938-0674
formatjournal
genrearticle
ristypeJOUR
abstract

To evaluate the effectiveness of colorectal cancer (CRC) screening in asymptomatic adults. A search was conducted of the Medline, Embase, and the Cochrane Library databases. A targeted search of PubMed was conducted for on-topic randomized controlled trials (RCTs). Meta-analysis across 4 RCTs for guaiac fecal occult blood testing (gFOBT) and flexible sigmoidoscopy (FS) screening showed a reduction of 18% (risk ratio [RR], 0.82; 95% CI [CI], 0.73-0.92) and 26% (RR, 0.74; 95% CI, 0.67-0.83) in CRC mortality for the screening group compared to controls, respectively. The number needed to screen (NNS) were 377 (95% CI, 249-887) and 864 (95% CI, 672-1266) for gFOBT and FS screening, respectively. A reduction of 8% and 27% in incidence of late-stage CRC was also observed for gFOBT and FS screening, respectively, but both had no significant effect on all-cause mortality. A single RCT found that screening with immunochemical fecal occult blood test (iFOBT) had no significant impact on...

pubElsevier Inc
doi10.1016/j.clcc.2016.03.003
lad01Clinical Colorectal Cancer
date2016-12